MECHANISM OF INACTIVATION OF MYELOPEROXIDASE BY PROPYLTHIOURACIL

被引:49
作者
LEE, E [1 ]
MIKI, Y [1 ]
KATSURA, H [1 ]
KARIYA, K [1 ]
机构
[1] KOBE GAKUIN UNIV,FAC PHARMACEUT SCI,DEPT PHARMACOL,NISHI KU,KOBE 673,JAPAN
关键词
D O I
10.1016/0006-2952(90)90428-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanism of inactivation of myeloperoxidase purified from rat bone marrow by propylthiouracil (PTU) was studied. PTU inhibited not only the peroxidase activity but also the chlorinating activity of myeloperoxidase in a concentration dependent manner. When myeloperoxidase was treated with PTU and hydrogen peroxide (5μM), inactivation of the enzyme was still observed after the excess reagents were removed by a column of Sephadex G-25. The treatment of the enzyme with PTU in the absence of hydrogen peroxide caused a slight inhibition of the enzyme activity. In addition, [14C]PTU became bound to myeloperoxidase in the presence of hydrogen peroxide. Difference spectrum of myeloperoxidase incubated with the small (0.1 mM) and large (2 mM) amounts of hydrogen peroxide revealed the formation of compounds II and III, respectively. Difference spectrum of myeloperoxidase treated with PTU in the presence of a low concentration of hydrogen peroxide (5 μM) was similar to that of compound II. Therefore, these results indicate that PTU inactivates myeloperoxidase through binding to the enzyme and the conversion to a compound II-like form in the presence of hydrogen peroxide. © 1990.
引用
收藏
页码:1467 / 1471
页数:5
相关论文
共 25 条
[1]  
Agner K., 1941, ACTA PHYS SCAND S8, V2, P1
[2]   DEVELOPMENT OF NEUTROPHILIC POLYMORPHONUCLEAR LEUKOCYTES IN HUMAN BONE MARROW - ORIGIN AND CONTENT OF AZUROPHIL AND SPECIFIC GRANULES [J].
BAINTON, DF ;
ULLYOT, JL ;
FARQUHAR, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 134 (04) :907-+
[3]   CHARACTERIZATION AND QUANTIFICATION OF PEROXIDASE IN HUMAN MONOCYTES [J].
BOS, A ;
WEVER, R ;
ROOS, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 525 (01) :37-44
[4]   IRREVERSIBLE INACTIVATION OF THYROID PEROXIDASE BY METHYLMERCAPTOIMIDAZOLE, THIOURACIL, AND PROPYLTHIOURACIL INVITRO AND ITS RELATIONSHIP TO INVIVO FINDINGS [J].
DAVIDSON, B ;
SOODAK, M ;
NEARY, JT ;
STROUT, HV ;
KIEFFER, JD ;
MOVER, H ;
MALOOF, F .
ENDOCRINOLOGY, 1978, 103 (03) :871-882
[6]  
DOERGE DR, 1986, BIOCHEMISTRY-US, V25, P4727
[7]   MECHANISM OF INACTIVATION OF THYROID PEROXIDASE BY THIOUREYLENE DRUGS [J].
ENGLER, H ;
TAUROG, A ;
NAKASHIMA, T .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (23) :3801-3806
[8]   REVERSIBLE AND IRREVERSIBLE INHIBITION OF THYROID PEROXIDASE-CATALYZED IODINATION BY THIOUREYLENE DRUGS [J].
ENGLER, H ;
TAUROG, A ;
LUTHY, C ;
DORRIS, ML .
ENDOCRINOLOGY, 1983, 112 (01) :86-95
[9]   COMPOUND-I OF MYELOPEROXIDASE [J].
HARRISON, JE ;
ARAISO, T ;
PALCIC, MM ;
DUNFORD, HB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 94 (01) :34-40
[10]  
HARRISON JE, 1976, J BIOL CHEM, V251, P1371